EUVIMEDEUVIMED entdecken
Metaanalyse

Prevalence of metabolic dysfunction-associated steatotic liver disease among obese, overweight, and at-risk children and adolescents in Türkiye: A meta-analysis

Prävalenz der metabolischen Dysfunktion-assoziierten steatotischen Lebererkrankung bei adipösen, übergewichtigen und gefährdeten Kindern und Jugendlichen in Türkiye: Meta-Analyse

Eda Kaya, Caglayan Keklikkiran, Mehlika Toy, Yusuf Yilmaz

Hepatology Forum · 2026 · 7 (4) · 361-373

DOI: 10.14744/hf.2026.88519 ↗

Auf einen Blick

Bei gefährdeten Kindern und Jugendlichen in Türkiye lag die gepoolte MASLD-Prävalenz bei 44,6 %. In Untergruppen war sie bei Jungen höher als bei Mädchen.

Fragestellung

Wie hoch ist die Prävalenz von MASLD bei adipösen, übergewichtigen oder anderweitig gefährdeten Kindern und Jugendlichen in Türkiye?

Methode

Meta-Analyse von Studien in Englisch und/oder Türkisch (2005 bis 2023) aus MEDLINE, PubMed, EMBASE und ULAKBIM.

Ergebnisse

Gepoolte MASLD-Prävalenz: 44,6 % (95 %-KI 39,5–49,7) bei gefährdeten Kindern und Jugendlichen; I2=96 %. Jungen: 54,9 % (95 %-KI 48,6–61,1); Mädchen: 41,2 % (95 %-KI 35,6–46,9).

Einschränkungen

Deutliche Heterogenität zwischen den Studien (I2=96 %).

Schlussfolgerung der Autor:innen

Die Ergebnisse zeigen eine deutlich hohe Prävalenz von MASLD bei gefährdeten Kindern und Jugendlichen und sollen als Warnsignal für politische Entscheidungsträger dienen.

Kernaussagen

  • MASLD-Prävalenz bei gefährdeten Kindern/Jugendlichen: 44,6 %
  • Höhere Prävalenz bei Jungen als bei Mädchen
  • Deutliche regionale Unterschiede berichtet

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Metaanalyse in der Zeitschrift Hepatology Forum, 2026. Verfasst von Eda Kaya und 3 weiteren Autor:innen.

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim: Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly non-alcoholic fatty liver disease (NAFLD), is the most common chronic liver disease worldwide. Among children, the overall prevalence of MASLD is estimated at around 7%, and early manifestation is associated with a more severe prognosis. Despite this growing burden, no systematic analysis of pediatric MASLD prevalence in Türkiye has yet been conducted. Here, we aimed to estimate the pediatric MASLD prevalence among children with specific conditions in Türkiye. Materials and Methods: A comprehensive literature search was conducted for studies published in English and/or Turkish between 2005 and 2023 using the databases MED-LINE, PubMed, EMBASE, and ULAKBIM. The search strategy included the following terms: “Türkiye AND NAFLD AND Pediatric” and “Türkiye AND NAFLD AND Prevalence AND Chil-dren AND Adolescent.” The studies identified through this literature review were incor-porated into the meta-analysis, which included either obese/overweight or at-risk chil-dren or adolescents with specific conditions such as increased transaminases.

Results

The pooled overall prevalence of MASLD was estimated as 44.6% (95% confi-dence interval [CI]: 39.5–49.7) among at-risk children and adolescents. Heterogeneity among studies was considerable, with an I2 value of 96%, indicating substantial variabil-ity. Subgroup analysis showed a pooled prevalence of 54.9% in boys (95% CI: 48.6–61.1) and 41.2% in girls (95% CI: 35.6–46.9). Regionally, the prevalence was 49.0% (95% CI: 41.2–57.1) in the Marmara and Aegean regions, and 42.2% (95% CI: 35.3–49.1) in the Black Sea, Mediterranean, and Central Anatolian regions.

Conclusion

The results of this study indicate a markedly high prevalence of MASLD among at-risk children and adolescents. These findings should serve as an alert for policymakers to adapt healthcare strategies aimed at preventing childhood obesity and MASLD.Materials and Methods: A comprehensive literature search was conducted for studies published in English and/or Turkish between 2005 and 2023 using the databases MEDLINE, PubMed, EMBASE, and UlakBim. The search strategy included the following terms: “Türkiye AND NAFLD AND Pediatric” and “Türkiye AND NAFLD AND Prevalence AND Children AND Adolescent.” The studies identified through this literature review were incorporated into the meta-analysis, which included either obese/overweight or at-risk children or adolescents with specific conditions such as increased transaminases.

Results

The pooled overall prevalence of MASLD was estimated as 44.6% (95% confidence intervals [CI]: 39.5–49.7) among at-risk children and adolescents. Heterogeneity among studies was considerable, with an I2 value of 96%, indicating substantial variability. Subgroup analysis showed a pooled prevalence of 54.9% in boys (95% CI: 48.6–61.1) and 41.2% in girls (95% CI: 35.6–46.9). Regionally, the prevalence was 49.0% (95% CI: 41.2–57.1) in the Marmara and Aegean regions, and 42.2% (95% CI: 35.3–49.1) in the Black Sea, Mediterranean, and Central Anatolian regions.

Conclusion

The results of this study indicate a markedly high prevalence of MASLD among at-risk children and adolescents. These findings should serve as an alert for policymakers to adapt healthcare strategies aimed at preventing childhood obesity and MASLD.

Zitieren

APA

Kaya, E., Keklikkiran, C., Toy, M., & Yilmaz, Y. (2026). Prevalence of metabolic dysfunction-associated steatotic liver disease among obese, overweight, and at-risk children and adolescents in Türkiye: A meta-analysis. Hepatology Forum, 7(4), 361-373. https://doi.org/10.14744/hf.2026.88519

Vancouver

Kaya E, Keklikkiran C, Toy M, Yilmaz Y. Prevalence of metabolic dysfunction-associated steatotic liver disease among obese, overweight, and at-risk children and adolescents in Türkiye: A meta-analysis. Hepatology Forum. 2026;7(4):361-373. doi:10.14744/hf.2026.88519

BibTeX
@article{Kaya2026,
  author = {Kaya, Eda and Keklikkiran, Caglayan and Toy, Mehlika and Yilmaz, Yusuf},
  title = {Prevalence of metabolic dysfunction-associated steatotic liver disease among obese, overweight, and at-risk children and adolescents in Türkiye: A meta-analysis},
  journal = {Hepatology Forum},
  year = {2026},
  volume = {7},
  number = {4},
  pages = {361--373},
  doi = {10.14744/hf.2026.88519}
}
Kostenlos starten →